Search Results - "Sayer, Gabriel T"

Levels of Trimethylamine N-Oxide Remain Elevated Long Term After Left Ventricular Assist Device and Heart Transplantation and Are Independent From Measures of Inflammation and Gut Dysbiosis by Yuzefpolskaya, Melana, Bohn, Bruno, Javaid, Azka, Mondellini, Giulio M., Braghieri, Lorenzo, Pinsino, Alberto, Onat, Duygu, Cagliostro, Barbara, Kim, Andrea, Takeda, Koji, Naka, Yoshifumi, Farr, Maryjane, Sayer, Gabriel T., Uriel, Nir, Nandakumar, Renu, Mohan, Sumit, Colombo, Paolo C., Demmer, Ryan T.

“…BACKGROUNDTrimethylamine N-oxide (TMAO)-a gut-derived metabolite-is elevated in heart failure (HF) and linked to poor prognosis. We investigated variations in…”
Get full text

Left Ventricular Decompression During Speed Optimization Ramps in Patients Supported by Continuous-Flow Left Ventricular Assist Devices: Device-Specific Performance Characteristics and Impact on Diagnostic Algorithms by Uriel, Nir, MD, MSc, Levin, Allison P., BA, Sayer, Gabriel T., MD, Mody, Kanika P., MD, Thomas, Sunu S., MD, Adatya, Sirtaz, MD, Yuzefpolskaya, Melana, MD, Garan, Arthur R., MD, Breskin, Alexander, BA, Takayama, Hiroo, MD, PhD, Colombo, Paolo C., MD, Naka, Yoshifumi, MD, PhD, Burkhoff, Daniel, MD, Jorde, Ulrich P., MD

“…Abstract Background Echocardiographic ramp tests have been widely used to help guide speed adjustments and for identification of potential device malfunctions…”
Get full text

Influence of Atrial Fibrillation on Functional Tricuspid Regurgitation in Patients With HeartMate 3 by Hayashi, Hideyuki, Naka, Yoshifumi, Sanchez, Joseph, Takayama, Hiroo, Kurlansky, Paul, Ning, Yuming, Topkara, Veli K, Yuzefpolskaya, Melana, Colombo, Paolo C, Sayer, Gabriel T, Uriel, Nir, Takeda, Koji

“…Background Functional tricuspid regurgitation (TR) can occur secondary to atrial fibrillation (AF). The impact of AF on functional TR and cardiovascular events…”
Get full text

The difference between cystatin C‐ and creatinine‐based assessment of kidney function in acute heart failure by Pinsino, Alberto, Fabbri, Matteo, Braghieri, Lorenzo, Bohn, Bruno, Gaudig, Antonia J., Kim, Andrea, Takeda, Koji, Naka, Yoshifumi, Sayer, Gabriel T., Uriel, Nir, Demmer, Ryan T., Faillace, Robert T., Husain, Syed A., Mohan, Sumit, Colombo, Paolo C., Yuzefpolskaya, Melana

“…Aims Acute heart failure (HF) is associated with muscle mass loss, potentially leading to overestimation of kidney function using serum creatinine‐based…”
Get full text

Right Ventricular Performance in Chronic Congestive Heart Failure by Sayer, Gabriel T., MD, Semigran, Marc J., MD

“…Right ventricular physiology is characterized by its close relationship with the pulmonary circuit. The right ventricle can accommodate significant changes in…”
Get full text

Early outcomes in heart transplantation using donation after circulatory death donors in patients bridged with durable left ventricular assist devices by Moroi, Morgan K., Patel, Krushang, Rajesh, Kavya, Lin, Allison, Wang, Pengchen, Wang, Chunhui, Zhao, Yanling, Kurlansky, Paul A., Latif, Farhana, Sayer, Gabriel T., Uriel, Nir, Naka, Yoshifumi, Takeda, Koji

“…Donation after circulatory death heart transplantation potentially increases donor allografts, especially for patients with lower listing status. We assessed…”
Get full text

Recovery With Temporary Mechanical Circulatory Support While Waitlisted for Heart Transplantation by Topkara, Veli K., Sayer, Gabriel T., Clerkin, Kevin J., Wever-Pinzon, Omar, Takeda, Koji, Takayama, Hiroo, Selzman, Craig H., Naka, Yoshifumi, Burkhoff, Daniel, Stehlik, Josef, Farr, Maryjane A., Fang, James C., Uriel, Nir, Drakos, Stavros G.

“…The 2018 U.S. heart allocation system offers an accelerated pathway for heart transplantation to the most urgent patients. This study sought to determine…”
Get full text

Advances in the pathophysiology and treatment of heart failure with preserved ejection fraction by Tannenbaum, Sara, Sayer, Gabriel T

“…PURPOSE OF REVIEWWith the failure of multiple trials to identify a successful therapy for heart failure with preserved ejection fraction (HFpEF), attention has…”
Get full text

Left Atrial Appendage Occlusion With Left Ventricular Assist Device Decreases Thromboembolic Events by Deshmukh, Amrish, Bhatia, Ankit, Sayer, Gabriel T., Kim, Gene, Raikhelkar, Jayant, Imamura, Teruhiko, Ozcan, Cevher, Ota, Takeyoshi, Jeevanandam, Valluvan, Uriel, Nir

“…Thromboembolic events (TEs) are common adverse events with continuous-flow left ventricular assist devices (LVADs). Left atrial appendage occlusion (LAAO) is…”
Get full text

Bridging to transplant with HeartMate 3 left ventricular assist devices in the new heart organ allocation system: An individualized approach by Uriel, Matan H., Clerkin, Kevin J., Takeda, Koji, Naka, Yoshifumi, Sayer, Gabriel T., Uriel, Nir, Topkara, Veli K.

“…Following the MOMENTUM 3 trial and the discontinuation of the HeartWare HVAD, the HeartMate 3 LVAD (HM 3) has become the main durable device for bridging to…”
Get full text

Medium-Term Outcomes of Concomitant Aortic Valve Repair in Patients with Continuous-Flow Left Ventricular Assist Device by Hynds, Melissa A., Hayashi, Hideyuki, Kurlansky, Paul, Zhao, Yanling, Vinogradsky, Alice V., Yuzefpolskaya, Melana, Colombo, Paolo C., Sayer, Gabriel T., Uriel, Nir, Naka, Yoshifumi, Takeda, Koji

“…Our objective was to analyze the development of aortic insufficiency in patients who received central aortic valve repair when undergoing continuous-flow left…”
Get full text

Evolution of Mechanical Circulatory Support for advanced heart failure by Moeller, Cathrine M., Valledor, Andrea Fernandez, Oren, Daniel, Rubinstein, Gal, Sayer, Gabriel T., Uriel, Nir

“…This comprehensive review highlights the significant advancements in Left Ventricular Assist Device (LVAD) therapy, emphasizing its evolution from the early…”
Get full text

Durable left ventricular assist devices as a bridge to transplantation in The Old and The New World by Fernandez Valledor, Andrea, Rubinstein, Gal, Moeller, Cathrine M., Lorenzatti, Daniel, Rahman, Salwa, Lee, Changhee, Oren, Daniel, Farrero, Marta, Sayer, Gabriel T., Uriel, Nir

“…Heart transplantation remains the gold standard treatment for end-stage heart failure patients without contraindications. However, limited donor availability…”
Get full text

National outcomes of bridge to multiorgan cardiac transplantation using mechanical circulatory support by Melehy, Andrew, Sanchez, Joseph E., Nemeth, Samantha K., Kurlansky, Paul A., Uriel, Nir, Sayer, Gabriel T., Naka, Yoshifumi, Takeda, Koji

“…Little is known regarding the profile of patients with multiorgan failure listed for simultaneous cardiac transplantation and secondary organ. In addition, few…”
Get full text

Acute right ventricular geometric change predicts outcomes in HeartMate 3 patients by Hayashi, Hideyuki, Kirschner, Michael, Vinogradsky, Alice, Ning, Yuming, Kurlansky, Paul, Yuzefpolskaya, Melana, Colombo, Paolo C., Sayer, Gabriel T., Uriel, Nir, Naka, Yoshifumi, Takeda, Koji

“…The physiological response of the right ventricle (RV) following left ventricular assist device (LVAD) implantation is difficult to predict. We aimed to…”
Get full text

The Difference Between Cystatin C– and Creatinine-Based Estimated GFR in Heart Failure With Reduced Ejection Fraction: Insights From PARADIGM-HF by Pinsino, Alberto, Carey, Matthew R., Husain, Syed, Mohan, Sumit, Radhakrishnan, Jai, Jennings, Douglas L., Nguonly, Austin S., Ladanyi, Annamaria, Braghieri, Lorenzo, Takeda, Koji, Faillace, Robert T., Sayer, Gabriel T., Uriel, Nir, Colombo, Paolo C., Yuzefpolskaya, Melana

“…The clinical implications of the discrepancy between cystatin C (cysC)– and serum creatinine (Scr)–estimated glomerular filtration rate (eGFR) in patients with…”
Get full text

Invasive Right Ventricular Pressure-Volume Analysis: Basic Principles, Clinical Applications, and Practical Recommendations by Brener, Michael I., Masoumi, Amirali, Ng, Vivian G., Tello, Khodr, Bastos, Marcelo B., Cornwell, William K., Hsu, Steven, Tedford, Ryan J., Lurz, Philipp, Rommel, Karl-Philipp, Kresoja, Karl-Patrik, Nagueh, Sherif F., Kanwar, Manreet K., Kapur, Navin K., Hiremath, Gurumurthy, Sarraf, Mohammad, Van Den Enden, Antoon J.M., Van Mieghem, Nicolas M., Heerdt, Paul M., Hahn, Rebecca T., Kodali, Susheel K., Sayer, Gabriel T., Uriel, Nir, Burkhoff, Daniel

“…Right ventricular pressure-volume (PV) analysis characterizes ventricular systolic and diastolic properties independent of loading conditions like volume…”
Get full text

Validation of the HeartMate 3 survival risk score in a large left ventricular assist device center by Moeller, Cathrine M, Rubinstein, Gal, Oren, Daniel, Valledor, Andrea Fernandez, Lotan, Dor, Raikhelkar, Jayant K, Clerkin, Kevin J, Colombo, Paolo C, Leahy, Nicole E, Fried, Justin A, Kaku, Yuji, Naka, Yoshifumi, Takeda, Koji, Yuzefpolskaya, Melana, Topkara, Veli K, Sayer, Gabriel T, Uriel, Nir

“…The HeartMate 3 survival risk score was recently validated in the Multicenter study Of MagLev Technology in Patients Undergoing Mechanical Circulatory Support…”
Get full text

Kidney function assessment using cystatin C and serum creatinine in heart transplantation recipients: Implications for valganciclovir dosing by Pinsino, Alberto, Jennings, Douglas L., Ladanyi, Annamaria, Duong, Phuong, Sweat, Austin O., Mahoney, Ian, Bohn, Bruno, Demmer, Ryan T., Takeda, Koji, Sayer, Gabriel T., Uriel, Nir, Leb, Jay S., Husain, Syed A., Mohan, Sumit, Colombo, Paolo C., Yuzefpolskaya, Melana

“…Among heart transplantation (HT) recipients, the accuracy of serum creatinine (sCr)-based estimated glomerular filtration rate (eGFR) may be limited by…”
Get full text

Safety of reduced anti-thrombotic strategy in patients with HeartMate 3 left ventricular assist device by Marshall, Dylan, Sanchez, Joseph, Yuzefpolskaya, Melana, Sayer, Gabriel T., Takeda, Koji, Naka, Yoshifumi, Colombo, Paolo C., Uriel, Nir, Topkara, Veli K.

“…There are limited safety data on reduced anti-thrombotic therapy (RT) in patients with HeartMate 3 (HM3) left ventricular assist device (LVAD). We conducted a…”
Get full text